<DOC>
	<DOCNO>NCT00799604</DOCNO>
	<brief_summary>This study design evaluate pharmacodynamics bolus dose regimen clevidipine , vascular-selective L-type calcium channel antagonist , management blood pressure cardiac surgery patient , well evaluate efficacy , safety pharmacokinetics clevidipine bolus administration .</brief_summary>
	<brief_title>Clevidipine Bolus Administration Treatment Hypertensive Patients Undergoing Cardiac Surgery ( SPRINT )</brief_title>
	<detailed_description>Study participant screen 14 day prior elective cardiac surgery . For purpose study , hypertension define systolic blood pressure ( SBP ) ≥140 mm Hg immediately prior initiation study drug . On day surgery , IV bolus dose clevidipine ( Bolus 1 - pre-anesthesia ) administer eligible study participant Treatment Period 1 decrease BP induction general anesthesia . The dose ( either 125 μg , 250 μg 500 μg ) give base assign cohort participant , list 'Arms ' section . At discretion investigator , second IV bolus dose clevidipine ( Bolus 2 - anesthesia ) could administer Treatment Period 2 either 125 μg , 250 μg 500 μg , base upon early observed response Bolus 1 . This dose administer induction anesthesia , decrease BP prior cannulation ascend aorta initiation cardiopulmonary bypass . Assessment safety perform throughout Treatment Periods 1 2 Adverse Events ( AEs ) follow 6 hour post final bolus dose Serious Adverse Events ( SAEs ) follow 24 hour post final bolus dose .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Clevidipine</mesh_term>
	<criteria>Require elective cardiac operation involve use cardiopulmonary bypass Age 18 year old A history hypertension and/or expect require perioperative antihypertensive therapy opinion investigator Written inform consent Preanesthesia baseline SBP ≥140 mm Hg prior bolus , measure use arterial line Receiving either intravenous vasopressor intravenous vasodilatory therapy 72 hour prior dose Critical leave main coronary artery stenosis Critical aortic valve ( &lt; 0.5 cm3 ) mitral valve ( &lt; 1.0 cm3 ) stenosis Acute myocardial infarction within prior 14 day Fully pace cardiac rhythm Known suspect aortic dissection Requiring preoperative intraaortic balloon pump counterpulsation therapy Contraindication transesophageal echocardiography Positive pregnancy test breast feed Intolerance allergy calcium channel blocker Allergy soybean oil egg lecithin Any condition ( ) Investigator 's opinion would warrant exclusion study prevent patient complete study Participation clinical research study involve evaluation investigational drug device within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Antihypertensive Agent</keyword>
	<keyword>Calcium Channel Blocker</keyword>
</DOC>